CellWell record HH-609583
Inflammation-triggered nanodrug delivery microneedles targeting pathogenic COX2+ endothelial cell-mediated glycocalyx degradation to ameliorate psoriasis
Zelin Ou; Keyi Zou; Linxi Zeng; Jingyi Wang; Huan Yang; Yuting Cao; Shuhan Wei; Yue Li; Yunxuan Zhang; Haibo Wang; Hua Wang; Bibo Ren; Xiaoyan Luo
2027
In plain language
In psoriasis-related experiments, a microneedle platform delivering an anthelmintic drug increased endothelial glycocalyx coverage from 11.9% to 87.5% and reduced immune cell infiltration.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-609583
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.